Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Acute LU-135252 produces hemodynamic improvement without neurohumoral stimulation in CHF

July 26, 2000

Linear pharmacokinetics, good tolerance reported for SKP-450 in healthy volunteers

July 25, 2000

Renally impaired subjects tolerate AMP-579 well, without dose adjustment

July 25, 2000

Gene for primary pulmonary hypertension exclusively licensed to United Therapeutics

July 24, 2000

New ACAT inhibitors patented in Japan particularly useful as antiatherosclerotics

July 21, 2000

Sumitomo describes new compounds for cardiovascular disorders

July 21, 2000

Advances in gene therapy for preventing restenosis reported in Vancouver

July 21, 2000

Beneficial effects described at World Congress on Heart Failure for enrasentan in SHRSP-HSHF model

July 21, 2000

Added benefit of ET blockade and angiotensin receptor antagonism in CHF

July 20, 2000

SM-20550 provides protection against I/R-induced skeletal muscle injury

July 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...